Top Markets
Coin of the day
Zhejiang Starry Pharmaceutical Co.,Ltd. Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520
Rank in Stocks #12607
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry... Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
Share Price
$1.29
Market Cap
$567.34M
Change (1 day)
-1.33%
Change (1 year)
-20.72%
Country
CN
Trade Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)

Category

EPS for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)
EPS as of 2026 TTM: 0
According to Zhejiang Starry Pharmaceutical Co.,Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Zhejiang Starry Pharmaceutical Co.,Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors